ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

Upton Briefed On Problems; To Start July 25

July 15, 1977

Cancer Care Cost To Jump by 27 Percent In a Decade, Reaching $158 Billion in 2020

January 28, 2011

Search Committee Sends Short List For NCI Director To HHS, White House

April 7, 1995

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003